Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Diflunisal and indomethacin were compared in patients with acute lumbago in a double-blind prospective clinical trial. The dosage of diflunisal was 500 mg twice daily (d-group) and the dosage of indomethacin 50 mg three times daily (i-group). Out of 133 patients, 66 were in the d-group and 67 in the...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/2937744
データ提供:米国国立医学図書館(NLM)
Acute Low Back Pain: Comparing Diflunisal and Indomethacin
The desert of pain management is vast and complex, with a variety of treatments available for acute low back pain. This study compares the effectiveness of two non-steroidal anti-inflammatory drugs (NSAIDs), diflunisal and indomethacin, in relieving acute lumbago. The authors conducted a double-blind prospective clinical trial to assess the efficacy and safety of these medications in patients experiencing acute low back pain. The study revealed that both medications were effective in reducing pain and improving functional disability, but diflunisal demonstrated a slightly better safety profile.
Diflunisal Shows Similar Efficacy with Fewer Side Effects
The study concluded that diflunisal was as effective as indomethacin in relieving acute low back pain, but it was associated with fewer reports of side effects. This finding suggests that diflunisal may be a preferable option for patients seeking relief from acute low back pain while minimizing the risk of adverse effects. However, further research is necessary to confirm these findings and explore the long-term safety of diflunisal in managing acute low back pain.
Navigating the Choices in Pain Management
The choice of medication for acute low back pain is a critical decision that should be made in consultation with a healthcare professional. This study highlights the importance of considering both efficacy and safety when selecting an NSAID for managing acute lumbago. It emphasizes the need for personalized treatment approaches based on individual patient needs and medical history.
Dr.Camel's Conclusion
The desert of pain management is full of diverse remedies, each offering unique strengths and limitations. Diflunisal, like a resilient desert plant that thrives in harsh conditions, provides effective pain relief with minimal side effects. However, as with any treatment, the journey to pain relief is individual and requires careful consideration of personal needs and medical history. We must remain vigilant in our quest for safe and effective pain management, embracing the diverse landscape of medical options available to us.
Date :
- Date Completed 1986-05-07
- Date Revised 2013-11-21
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.